David L Hughes Selected Research

Dolichol Monophosphate Mannose

3/2009

First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David L Hughes Research Topics

Disease

1	COVID-19 12/2020
1	Giardiasis 10/2018
1	Breast Neoplasms (Breast Cancer) 10/2017
1	Adenoma (Adenomas) 10/2017
1	Lung Neoplasms (Lung Cancer) 10/2017
1	Edema (Dropsy) 01/2017
1	Hyperalgesia 01/2017
1	African Trypanosomiasis (Nagana) 03/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2006

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 10/2018 - 03/2009
1	Chalcone (Benzalacetophenone)IBA 12/2020
1	SARS-CoV-2 3C-like proteinaseIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	LigandsIBA 12/2020
1	Albendazole (Albenza)FDA Link 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	EstersIBA 10/2017
1	carbeneIBA 10/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	CarrageenanIBA 01/2017
1	BucladesineIBA 01/2017
1	Dipyrone (Metamizole)IBA 01/2017
1	Dolichol Monophosphate MannoseIBA 03/2009
1	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 03/2009
1	BoratesIBA 08/2006
1	SaltsIBA 08/2006

Therapy/Procedure

1	Therapeutics 03/2009